4.8 Article

A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

Engineering Escherichia coli to produce Bordetella pertussis oligosaccharide with multiple trisaccharide units

Zhen Wang et al.

Summary: The immunogenicity of pertussis vaccine can be enhanced by adding Bordetella pertussis oligosaccharide with multiple trisaccharide units. This study engineered Escherichia coli to produce B. pertussis oligosaccharides with multiple trisaccharide units, leading to improved immune response efficiency.

METABOLIC ENGINEERING (2022)

Article Immunology

Pertussis Disease and Antenatal Vaccine Effectiveness in Australian Children

Helen E. Quinn et al.

Summary: Maternal antenatal vaccination can reduce the incidence of pertussis in infants under 2 months of age. Age-appropriate vaccination and control of comorbidities are also important for preventing pertussis in children.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

Article Immunology

Pertussis in Asia: Recent country-specific data and recommendations

Pramod Jog et al.

Summary: This article introduces the Global Pertussis Initiative (GPI) Roundtable Meeting held in 2019, focusing on the incidence, surveillance, and immunization practices for pertussis in the Asian region. Many Asian countries have seen an increase in pertussis cases, with underreporting being a concern. Improved surveillance and awareness of pertussis, as well as the enhancement of infant and childhood vaccination schedules, are needed.

VACCINE (2022)

Article Chemistry, Physical

Orthogonal modular biosynthesis of nanoscale conjugate vaccines for vaccination against infection

Xin Li et al.

Summary: The research utilized the SpyTag/SpyCatcher system to produce nanoconjugate vaccines, demonstrating efficient prophylactic effects by conjugating polysaccharides onto the surfaces of virus-like particles.

NANO RESEARCH (2022)

Article Microbiology

The Mechanism of Pertussis Cough Revealed by the Mouse-Coughing Model

Yukihiro Hiramatsu et al.

Summary: The Gram-negative bacterium Bordetella pertussis causes whooping cough, a respiratory disease characterized by paroxysmal coughing. However, the mechanism of coughing has not been extensively studied. In this study, a mouse model was used to reproduce coughing after intranasal inoculation with the bacterium. It was found that lipooligosaccharide, Vag8, and pertussis toxin of the bacteria cooperatively function to cause coughing. Bradykinin and TRPV1 were identified as host factors involved in the coughing mechanism.
Review Immunology

Pertussis vaccines and protective immunity

Parul Kapil et al.

CURRENT OPINION IN IMMUNOLOGY (2019)

Article Cell Biology

The impact of past vaccination coverage and immunity on pertussis resurgence

Matthieu Domenech de Celles et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Article Infectious Diseases

An update of the global burden of pertussis in children younger than 5 years: a modelling study

Karene Hoi Ting Yeung et al.

LANCET INFECTIOUS DISEASES (2017)

Article Immunology

Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis

Jason M. Warfel et al.

CLINICAL AND VACCINE IMMUNOLOGY (2016)

Review Microbiology

Pertussis: Microbiology, Disease, Treatment, and Prevention

Paul E. Kilgore et al.

CLINICAL MICROBIOLOGY REVIEWS (2016)

Article Medicine, General & Internal

Asymptomatic transmission and the resurgence of Bordetella pertussis

Benjamin M. Althouse et al.

BMC MEDICINE (2015)

Article Multidisciplinary Sciences

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

Jason M. Warfel et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Biochemistry & Molecular Biology

Comparison of lipopolysaccharide structures of Bordetella pertussis clinical isolates from pre- and post-vaccine era

Sami AlBitar-Nehme et al.

CARBOHYDRATE RESEARCH (2013)

Article Multidisciplinary Sciences

Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine

Joanna Kubler-Kielb et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Editorial Material Immunology

The Present and Future Control of Pertussis

James D. Cherry

CLINICAL INFECTIOUS DISEASES (2010)

Editorial Material Immunology

Pertussis Vaccine A Critique

John B. Robbins et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)